Add to ORKGChildren with acute lymphoblastic leukemia (ALL), treated with L-asparaginase are at risk for cerebral thrombosis or hemorrhage because of coagulation protein deficiencies. The results and the importance of serial neuropsychological examination after such complications in three children with ALL are presented. All patients showed marked aphasia and other cognitive deficits. Recovery was complete in two of three children.</p
BACKGROUND: The outcome of childhood acute lymphoblastic leukemia has improved because of intensive ...
International audienceCentral nervous system (CNS) thrombotic events are a well-known complication o...
Asparaginase is an integral component of multiagent chemotherapy regimens for the treatment of child...
Children with acute lymphoblastic leukemia (ALL), treated with L-asparaginase are at risk for cerebr...
Abstract The occurrence of thrombosis complicating L-asparaginase therapy in childhood acute lymphob...
The occurrence of thrombosis complicating L-asparaginase therapy in childhood acute lymphoblastic le...
Background Bleeding, one of the most common symptoms of acute leukemia in untreated patients, is mos...
We report a 9-year-old boy with acute lymphoblastic leukemia (ALL) in high-risk group who suffered f...
L-asparaginase is commonly used in the chemotherapy regimens for acute lymphoblastic leukaemia. Its ...
L-asparaginase is an important drug in the treatment of childhood acute lymphoblastic leukaemia (ALL...
20 children with acute lymphoblastic leukaemia (13 children with first manifestation of ALL and 4 ch...
Background: L-asparaginase, a key therapeutic agent in the management of patients with acute lymphob...
SUMMARY We have reviewed the neurological complications not directly attributable to leukaemic infil...
ombination chemotherapy in childhood acute lymphoblastic leukemia (ALL) using prednisone, vincristin...
Intensive chemotherapy in the treatment of children with acute lymphoblastic leukemia (ALL) has dram...
BACKGROUND: The outcome of childhood acute lymphoblastic leukemia has improved because of intensive ...
International audienceCentral nervous system (CNS) thrombotic events are a well-known complication o...
Asparaginase is an integral component of multiagent chemotherapy regimens for the treatment of child...
Children with acute lymphoblastic leukemia (ALL), treated with L-asparaginase are at risk for cerebr...
Abstract The occurrence of thrombosis complicating L-asparaginase therapy in childhood acute lymphob...
The occurrence of thrombosis complicating L-asparaginase therapy in childhood acute lymphoblastic le...
Background Bleeding, one of the most common symptoms of acute leukemia in untreated patients, is mos...
We report a 9-year-old boy with acute lymphoblastic leukemia (ALL) in high-risk group who suffered f...
L-asparaginase is commonly used in the chemotherapy regimens for acute lymphoblastic leukaemia. Its ...
L-asparaginase is an important drug in the treatment of childhood acute lymphoblastic leukaemia (ALL...
20 children with acute lymphoblastic leukaemia (13 children with first manifestation of ALL and 4 ch...
Background: L-asparaginase, a key therapeutic agent in the management of patients with acute lymphob...
SUMMARY We have reviewed the neurological complications not directly attributable to leukaemic infil...
ombination chemotherapy in childhood acute lymphoblastic leukemia (ALL) using prednisone, vincristin...
Intensive chemotherapy in the treatment of children with acute lymphoblastic leukemia (ALL) has dram...
BACKGROUND: The outcome of childhood acute lymphoblastic leukemia has improved because of intensive ...
International audienceCentral nervous system (CNS) thrombotic events are a well-known complication o...
Asparaginase is an integral component of multiagent chemotherapy regimens for the treatment of child...